Precise definition of Your Parkinson's


As there is no biomarker for Parkinson’s disease, diagnosis takes a long time and can be inaccurate. This delays patient treatment and reduces clinical trial success.


PARKS enables quick, and accurate diagnosis of Parkinson’s based on measuring the levels of specific protein signatures in blood.


Our biomarker test will facilitate faster and more accurate diagnosis and disease follow up, leading to improved treatment for patients.